Kirin (OTCMKTS:KNBWY) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Kirin (OTCMKTS:KNBWY) posted its quarterly earnings results on Wednesday. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.09, Zacks reports. Kirin had a net margin of 7.79% and a return on equity of 12.22%.

Kirin Stock Down 3.3%

KNBWY traded down $0.63 during trading hours on Wednesday, hitting $18.66. 30,730 shares of the company’s stock were exchanged, compared to its average volume of 28,601. Kirin has a 12-month low of $14.66 and a 12-month high of $20.21. The firm has a 50 day moving average of $18.40 and a 200 day moving average of $17.36. The company has a current ratio of 1.48, a quick ratio of 1.02 and a debt-to-equity ratio of 0.48. The firm has a market cap of $15.12 billion, a P/E ratio of 11.89 and a beta of 0.05.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Kirin from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. One investment analyst has rated the stock with a Hold rating. According to MarketBeat.com, the company presently has an average rating of “Hold”.

About Kirin

Kirin Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets. The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.